z-logo
Premium
Clinicopathologic consequences following discontinuation of rifaximin in patients with sickle cell disease
Author(s) -
Lim Seah H.,
Dutta Dibyendu
Publication year - 2020
Publication title -
american journal of hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.456
H-Index - 105
eISSN - 1096-8652
pISSN - 0361-8609
DOI - 10.1002/ajh.25798
Subject(s) - rifaximin , medicine , gastroenterology , enterocyte , cirrhosis , antibiotics , immunology , small intestine , microbiology and biotechnology , biology

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom